ISO 20012:2026
ISO 20012:2026 Biotechnology — Biobanking — Requirements for human natural killer cells derived from pluripotent stem cells
CDN $251.00
This publication was last reviewed and confirmed in 2026.
Biotechnology — Biobanking — Requirements for human natural killer cells derived from pluripotent stem cells
Description
This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.
Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.
This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.
This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.
NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.
Edition
1
Published Date
2026-06-19
Status
PUBLISHED
Pages
22
Language
English
Format
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.
Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.
This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.
This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.
NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 6707:2022 Buildings and civil engineering works – Vocabulary – Part 3: Sustainability terms
CDN $82.00 Add to cart -
ISO 23066:2021 Vocabulary related to rattan materials and products
CDN $82.00 Add to cart -
ISO 6405:2017 Earth-moving machinery – Symbols for operator controls and other displays – Part 2: Symbols for specific machines, equipment and accessories
CDN $379.00 Add to cart -
ISO 20480:2021 Fine bubble technology – General principles for usage and measurement of fine bubbles – Part 3: Methods for generating fine bubbles
CDN $186.00 Add to cart
